1199.32.81004 Boehringer Ingelheim Investigational Site

Kumagaya, Saitama

0 studies enrolling now · 1 studies all time

What they study most

Pulmonary Fibrosis

Studies at this site

• Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients — Completed